AIDS
Conditions
Interventions
Fuzhengkangai granule treatment group.:Fuzhengkangai granule
Fuzhengkangai granule control group:Placebo (5% Fuzhengkangai granule)
Sponsors
Hubei Provincial Hospital of Chinese Medicine
Eligibility
Sex/Gender
All
Age
16 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. In accordance with the western medicine HIV/AIDS diagnostic criteria, all patients were diagnosed by HIV screening and positive; 2. Conform to the "loss of vital qi, sediment poison knot" of traditional Chinese medicine syndrome differentiation standard; 3. In line with the western medicine effective antiretroviral therapy (HARRT) antiviral treatment indications. Conforms to the AIDS diagnosis and guide treatment (a line: zidovudine AZT300mg, bid or tenofovir TDF300mg, qd + 3 tc300mg lamivudine, bid + in the wayland EFV600mg, qd or nevirapine NVP200mg, qd) (CD4 < 500); 4. Participants aged 16-65 years old; Voluntary participants, and signed informed consent enters; 5. Nearly a month had not affected the test observation of drug therapy; 6. The disease diagnosis and syndrome differentiation standard, and ruled out in the following cases "exclusion criteria", can be incorporated into the test cases.
Exclusion criteria
Exclusion criteria: 1. Drug allergy or intolerance to the observation of this test; 2. Combined with severe cardiovascular and cerebrovascular diseases serious, severe liver, kidney and hematopoietic system disease, and mental disease; 3. Persons aged under 16 or over 65 years old, pregnant or lactating women 4. Other clinical trials or other traditional Chinese medicine therapy; 5. serious opportunistic infections.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood analysis;TCM symptom and sign score;Quality of life scale;CD4+T lymphocytes; | — |
Secondary
| Measure | Time frame |
|---|---|
| HIV viral load; | — |
Countries
China
Contacts
Public ContactLiu Jianzhong
Outcome results
None listed